Abstract
Rationale
Cannabis use among people with mood disorders increased in recent years. While comorbidity between cannabis use, cannabis use disorder (CUD), and mood disorders is high, the underlying mechanisms remain unclear.
Objectives
We aimed to evaluate (1) the epidemiological evidence for an association between cannabis use, CUD, and mood disorders; (2) prospective longitudinal, genetic, and neurocognitive evidence of underlying mechanisms; and (3) prognosis and treatment options for individuals with CUD and mood disorders.
Methods
Narrative review of existing literature is identified through PubMed searches, reviews, and meta-analyses. Evidence was reviewed separately for depression, bipolar disorder, and suicide.
Results
Current evidence is limited and mixed but suggestive of a bidirectional relationship between cannabis use, CUD, and the onset of depression. The evidence more consistently points to cannabis use preceding onset of bipolar disorder. Shared neurocognitive mechanisms and underlying genetic and environmental risk factors appear to explain part of the association. However, cannabis use itself may also influence the development of mood disorders, while others may initiate cannabis use to self-medicate symptoms. Comorbid cannabis use and CUD are associated with worse prognosis for depression and bipolar disorder including increased suicidal behaviors. Evidence for targeted treatments is limited.
Conclusions
The current evidence base is limited by the lack of well-controlled prospective longitudinal studies and clinical studies including comorbid individuals. Future studies in humans examining the causal pathways and potential mechanisms of the association between cannabis use, CUD, and mood disorder comorbidity are crucial for optimizing harm reduction and treatment strategies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abush H, Ghose S, Van Enkevort EA et al (2018) Associations between adolescent cannabis use and brain structure in psychosis. Psychiatry Res - Neuroimaging 276:53–64. https://doi.org/10.1016/j.pscychresns.2018.03.008
Agrawal A, Nurnberger JI, Lynskey MT (2011) Cannabis involvement in individuals with bipolar disorder. Psychiatry Res 185:459–461. https://doi.org/10.1016/j.psychres.2010.07.007
Agrawal A, Nelson EC, Littlefield AK et al (2012) Cannabinoid receptor genotype moderation of the effects of childhood physical abuse on anhedonia and depression. Arch Gen Psychiatry 69:732–740. https://doi.org/10.1001/archgenpsychiatry.2011.2273
Agrawal A, Nelson EC, Bucholz KK et al (2017a) Major depressive disorder, suicidal thoughts and behaviours, and cannabis involvement in discordant twins: a retrospective cohort study. The Lancet Psychiatry 4:706–714. https://doi.org/10.1016/S2215-0366(17)30280-8
Agrawal A, Tillman R, Grucza RA et al (2017b) Reciprocal relationships between substance use and disorders and suicidal ideation and suicide attempts in the Collaborative Study of the Genetics of Alcoholism. J Affect Disord. https://doi.org/10.1016/j.jad.2016.12.060
Alemany S, Arias B, Fatjó-Vilas M et al (2014) Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes. Acta Psychiatr Scand 129:54–62. https://doi.org/10.1111/acps.12108
American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Association, Arlington, VA
Angst J (2013) (2013) Bipolar disorders in DSM-5: strengths, problems and perspectives. Int J Bipolar Disord 11(1):1–3. https://doi.org/10.1186/2194-7511-1-12
Arendt M, Rosenberg R, Fjordback L et al (2007) Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol Med 37:935–945. https://doi.org/10.1017/S0033291706009688
Arias F, Szerman N, Vega P et al (2013) Alcohol abuse or dependence and other psychiatric disorders. Madrid study on the prevalence of dual pathology. Ment Heal Subst Use Dual Diagnosis 6:339–350. https://doi.org/10.1080/17523281.2012.748674
Arias AJ, Hammond CJ, Burleson JA et al (2020) Temporal dynamics of the relationship between change in depressive symptoms and cannabis use in adolescents receiving psychosocial treatment for cannabis use disorder. J Subst Abuse Treat 117:108087. https://doi.org/10.1016/j.jsat.2020.108087
Arnold LM (2003) Gender differences in bipolar disorder. Psychiatr Clin 26:595–620. https://doi.org/10.1016/S0193-953X(03)00036-4
Arsenault-Lapierre G, Kim C, Turecki G (2004) Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 4:1–11
Ashton CH, Moore PB, Gallagher P, Young AH (2005) Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential. J Psychopharmacol 19:293–300. https://doi.org/10.1177/0269881105051541
Bambico FR, Nguyen NT, Katz N, Gobbi G (2010) Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiol Dis 37:641–655. https://doi.org/10.1016/J.NBD.2009.11.020
Bartoli F, Crocamo C, Carrà G (2019) Cannabis use disorder and suicide attempts in bipolar disorder: a meta-analysis. Neurosci Biobehav Rev 103:14–20
Bersani G, Bersani FS, Caroti E et al (2016) Negative symptoms as key features of depression among cannabis users: a preliminary report. Eur Rev Med Pharmacol Sci 20:547–552
Bierut T, Krauss MJ, Sowles SJ, Cavazos-Rehg PA (2017) Exploring marijuana advertising on weedmaps, a popular online directory. Prev Sci 18:183–192. https://doi.org/10.1007/s11121-016-0702-z
Bitter SM, Adler CM, Eliassen JC et al (2014) Neurofunctional changes in adolescent cannabis users with and without bipolar disorder. Addiction 109:1901–1909. https://doi.org/10.1111/add.12668
Blanco C, Hasin DS, Wall MM et al (2016) Cannabis use and risk of psychiatric disorders: prospective evidence from aUS national longitudinal study. JAMA Psychiat 73:388–395. https://doi.org/10.1001/jamapsychiatry.2015.3229
Bluett RJ, Báldi R, Haymer A, et al (2017) Endocannabinoid signalling modulates susceptibility to traumatic stress exposure. Nat Commun 8: https://doi.org/10.1038/ncomms14782
Bolanis D, Orri M, Castellanos-Ryan N et al (2020) Cannabis use, depression and suicidal ideation in adolescence: direction of associations in a population based cohort. J Affect Disord 274:1076–1083. https://doi.org/10.1016/j.jad.2020.05.136
Bolton JM, Robinson J, Sareen J (2009) Self-medication of mood disorders with alcohol and drugs in the national epidemiologic survey on alcohol and related conditions. J Affect Disord 115:367–375. https://doi.org/10.1016/j.jad.2008.10.003
Bonaccorso S, Ricciardi A, Zangani C et al (2019) Cannabidiol (CBD) use in psychiatric disorders: a systematic review. Neurotoxicology 74:282–298. https://doi.org/10.1016/j.neuro.2019.08.002
Bonn-Miller MO, Boden MT, Bucossi MM, Babson KA (2014) Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. Am J Drug Alcohol Abuse 40:23–30. https://doi.org/10.3109/00952990.2013.821477
Bora E, Fornito A, Yücel M, Pantelis C (2010) Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 67:1097–1105. https://doi.org/10.1016/j.biopsych.2010.01.020
Borges G, Bagge CL, Orozco R (2016) A literature review and meta-analyses of cannabis use and suicidality. J Affect Disord 195:63–74. https://doi.org/10.1016/j.jad.2016.02.007
Borges G, Benjet C, Orozco R et al (2017) Alcohol, cannabis and other drugs and subsequent suicide ideation and attempt among young Mexicans. J Psychiatr Res 91:74–82. https://doi.org/10.1016/j.jpsychires.2017.02.025
Borkowska A, Rybakowski JK (2001) Neuropsychological frontal lobe tests indicate that bipolar depressed patients are more impaired than unipolar. Bipolar Disord 3:88–94. https://doi.org/10.1034/j.1399-5618.2001.030207.x
Bossong MG, Niesink RJM (2010) Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92:370–385. https://doi.org/10.1016/j.pneurobio.2010.06.010
Bossong MG, Van Berckel BNM, Boellaard R et al (2009) Δ9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34:759–766. https://doi.org/10.1038/npp.2008.138
Bossong MG, van Hell HH, Jager G et al (2013) The endocannabinoid system and emotional processing: a pharmacological fMRI study with {increment}9-tetrahydrocannabinol. Eur Neuropsychopharmacol 23:1687–1697. https://doi.org/10.1016/j.euroneuro.2013.06.009
Botsford SL, Yang S, George TP (2020) Cannabis and cannabinoids in mood and anxiety disorders: impact on illness onset and course, and assessment of therapeutic potential. Am J Addict 29:9–26
Bovasso GB (2001) Cannabis abuse as a risk factor for depressive symptoms. Am J Psychiatry 158:2033–2037. https://doi.org/10.1176/appi.ajp.158.12.2033
Braga RJ, Burdick KE, DeRosse P, Malhotra AK (2012) Cognitive and clinical outcomes associated with cannabis use in patients with bipolar I disorder. Psychiatry Res 200:242–245. https://doi.org/10.1016/j.psychres.2012.05.025
Canham SL, Mahmood A, Stalman MN et al (2018) Personal theories of substance use among middle-aged and older adults with bipolar disorder. Aging Ment Heal 22:813–818. https://doi.org/10.1080/13607863.2017.1299689
Carey CE, Agrawal A, Bucholz KK, et al (2016) Associations between polygenic risk for psychiatric disorders and substance involvement. Front Genet:149. https://doi.org/10.3389/FGENE.2016.00149
Carvalho AF, Stubbs B, Vancampfort D et al (2019) Cannabis use and suicide attempts among 86,254 adolescents aged 12–15 years from 21 low- and middle-income countries. Eur Psychiatry 56:8–13. https://doi.org/10.1016/j.eurpsy.2018.10.006
Chabrol H, Chassagne J, Henry L, Raynal P (2020) Influence of cannabis use disorder symptoms on suicidal ideation in college students. Int J Ment Health Addict. https://doi.org/10.1007/s11469-019-00201-2
Chaudhury S, Kumar S, Dixit V (2014) Symptom resolution in acute mania with co-morbid cannabis dependence. Saudi J Heal Sci 3:147. https://doi.org/10.4103/2278-0521.142322
Chye Y, Solowij N, Ganella EP et al (2017) Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms. Prog Neuro-Psychopharmacology Biol Psychiatry 79:392–400. https://doi.org/10.1016/j.pnpbp.2017.07.017
Clark L, Iversen SD, Goodwin GM (2001) A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 158:1605–1611. https://doi.org/10.1176/appi.ajp.158.10.1605
Cornelius JR, Bukstein OG, Douaihy AB et al (2010) Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend 112:39–45. https://doi.org/10.1016/j.drugalcdep.2010.05.010
Cougle JR, Hakes JK, Macatee RJ et al (2015) Quality of life and risk of psychiatric disorders among regular users of alcohol, nicotine, and cannabis: an analysis of the national epidemiological survey on alcohol and related conditions (NESARC). J Psychiatr Res 66–67:135–141. https://doi.org/10.1016/j.jpsychires.2015.05.004
Curran E, Perra O, Rosato M et al (2021) Complex childhood trauma, gender and depression: patterns and correlates of help-seeking and maladaptive coping. J Affect Disord 292:603–613. https://doi.org/10.1016/J.JAD.2021.06.011
Danielsson AK, Lundin A, Agardh E et al (2016) Cannabis use, depression and anxiety: a 3-year prospective population-based study. J Affect Disord 193:103–108. https://doi.org/10.1016/j.jad.2015.12.045
De Gregorio D, Dean Conway J, Canul ML et al (2020) Effects of chronic exposure to low-dose delta-9-tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behavior. Int J Neuropsychopharmacol 23:751–761. https://doi.org/10.1093/ijnp/pyaa058
De Hert M, Wampers M, Jendricko T et al (2011) Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophr Res 126:270–276. https://doi.org/10.1016/j.schres.2010.07.003
De Pradier M, Gorwood P, Beaufils B et al (2010) Influence of the serotonin transporter gene polymorphism, cannabis and childhood sexual abuse on phenotype of bipolar disorder: a preliminary study. Eur Psychiatry 25:323–327. https://doi.org/10.1016/j.eurpsy.2009.10.002
de la Fuente-Tomás L, Arranz B, Velasco A et al (2020) Sex differences in bipolar disorder: Impact of lifetime cannabis use on clinical course, functioning, and quality of life in bipolar disorder. J Affect Disord 266:258–262. https://doi.org/10.1016/j.jad.2020.01.043
Delforterie MJ, Lynskey MT, Huizink AC et al (2015) The relationship between cannabis involvement and suicidal thoughts and behaviors. Drug Alcohol Depend 150:98–104. https://doi.org/10.1016/j.drugalcdep.2015.02.019
Delphin-Rittmon ME, Flanagan EH, Andres-Hyman R et al (2015) Racial-ethnic differences in access, diagnosis, and outcomes in public-sector inpatient mental health treatment. Psychol Serv 12:158–166. https://doi.org/10.1037/A0038858
Demontis D, Rajagopal VM, Thorgeirsson TE et al (2019) (2019) Genome-wide association study implicates CHRNA2 in cannabis use disorder. Nat Neurosci 227(22):1066–1074. https://doi.org/10.1038/s41593-019-0416-1
Dunayevich E, Keck PE (2000) Prevalence and description of psychotic features in bipolar mania. Curr Psychiatry Rep 2:286–290
Ellison-Wright I, Bullmore E (2010) Anatomy of bipolar disorder and schizophrenia: a meta-analysis. Schizophr Res 117:1–12. https://doi.org/10.1016/j.schres.2009.12.022
Etain B, Henry C, Bellivier F et al (2008) Beyond genetics: childhood affective trauma in bipolar disorder. Bipolar Disord 10:867–876
Etain B, Lajnef M, Bellivier F et al (2017) Revisiting the association between childhood trauma and psychosis in bipolar disorder: a quasi-dimensional path-analysis. J Psychiatr Res 84:73–79. https://doi.org/10.1016/j.jpsychires.2016.09.022
Feingold D, Weiser M, Rehm J, Lev-Ran S (2015) The association between cannabis use and mood disorders: a longitudinal study. J Affect Disord 172:211–218. https://doi.org/10.1016/j.jad.2014.10.006
Feingold D, Rehm J, Lev-Ran S (2017) Cannabis use and the course and outcome of major depressive disorder: a population based longitudinal study. Psychiatry Res 251:225–234. https://doi.org/10.1016/j.psychres.2017.02.027
Fergusson DM, Horwood LJ, Swain-Campbell N (2002) Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 97:1123–1135. https://doi.org/10.1046/j.1360-0443.2002.00103.x
Ferland JMN, Hurd YL (2020) Deconstructing the neurobiology of cannabis use disorder. Nat Neurosci. https://doi.org/10.1038/s41593-020-0611-0
Foster KT, Li N, McClure EA et al (2016) Gender differences in internalizing symptoms and suicide risk among men and women seeking treatment for cannabis use disorder from late adolescence to middle adulthood. J Subst Abuse Treat 66:16–22. https://doi.org/10.1016/j.jsat.2016.01.012
Gibbs M, Winsper C, Marwaha S et al (2015) Cannabis use and mania symptoms: a systematic review and meta-analysis. J Affect Disord 171:39–47. https://doi.org/10.1016/j.jad.2014.09.016
Gobbi G, Atkin T, Zytynski T et al (2019) Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: a systematic review and meta-analysis. JAMA Psychiat 76:426–434. https://doi.org/10.1001/jamapsychiatry.2018.4500
Gorelick DA (2019) Psychiatric comorbidity of cannabis use disorder. In: Montoya I, Weiss S (eds) Cannabis Use Disorders. Springer, pp 113–125
Gorfinkel LR, Stohl M, Hasin D (2020) Association of depression with past-month cannabis use among US adults aged 20 to 59 years, 2005 to 2016. JAMA Netw Open 3:e2013802. https://doi.org/10.1001/jamanetworkopen.2020.13802
Green B, Kavanagh D, Young R (2003) Being stoned: a review of self-reported cannabis effects. Drug Alcohol Rev 22:453–460. https://doi.org/10.1080/09595230310001613976
Greenberg T, Fournier JC, Stiffler R et al (2020) Reward related ventral striatal activity and differential response to sertraline versus placebo in depressed individuals. Mol Psychiatry 25:1526–1536. https://doi.org/10.1038/s41380-019-0490-5
Gruber SA, Rogowska J, Yurgelun-Todd DA (2009) Altered affective response in marijuana smokers: an FMRI study. Drug Alcohol Depend 105:139–153. https://doi.org/10.1016/j.drugalcdep.2009.06.019
Gruber SA, Sagar KA, Dahlgren MK et al (2012) Marijuana impacts mood in bipolar disorder: a pilot study. Ment Heal Subst Use Dual Diagnosis 5:228–239. https://doi.org/10.1080/17523281.2012.659751
Halder A, Mukhopadhyay S, Biswas P, Biswas A (2016) Effects of cannabis use on cognitive function and clinical features of bipolar disorder. Int J Educ Psychol Res 2:213. https://doi.org/10.4103/2395-2296.189677
Halladay JE, Munn C, Boyle M, et al (2020) Temporal changes in the cross-sectional associations between cannabis use, suicidal ideation, and depression in a nationally representative sample of Canadian adults in 2012 compared to 2002. Can J Psychiatry. https://doi.org/10.1177/0706743719854071
Hasin DS, Kerridge BT, Saha TD et al (2016) Prevalence and correlates of DSM-5 cannabis use disorder, 2012–2013: findings from the national epidemiologic survey on alcohol and related conditions-III. Am J Psychiatry 173:588–599. https://doi.org/10.1176/appi.ajp.2015.15070907
Hayatbakhsh MR, Najman JM, Bor W et al (2009) Multiple risk factor model predicting cannabis use and use disorders: a longitudinal study. Am J Drug Alcohol Abuse 35:399–407. https://doi.org/10.3109/00952990903353415
Henquet C, Krabbendam L, de Graaf R et al (2006) Cannabis use and expression of mania in the general population. J Affect Disord 95:103–110. https://doi.org/10.1016/j.jad.2006.05.002
Hines LA, Freeman TP, Gage SH et al (2020) Association of high-potency cannabis use with mental health and substance use in adolescence. JAMA Psychiat 77:1044–1051. https://doi.org/10.1001/jamapsychiatry.2020.1035
Hodgson K, Almasy L, Knowles EEM et al (2017) The genetic basis of the comorbidity between cannabis use and major depression. Addiction. https://doi.org/10.1111/add.13558
Hodgson K, Coleman JRI, Hagenaars SP et al (2020) Cannabis use, depression and self-harm: phenotypic and genetic relationships. Addiction. https://doi.org/10.1111/add.14845
Hosseini S, Oremus M (2019) The effect of age of initiation of cannabis use on psychosis, depression, and anxiety among youth under 25 years. Can J Psychiatry 64:304–312. https://doi.org/10.1177/0706743718809339
Hulvershorn LA, Karne H, Gunn AD et al (2012) Neural activation during facial emotion processing in unmedicated bipolar depression, euthymia, and mania. Biol Psychiatry 71:603–610. https://doi.org/10.1016/j.biopsych.2011.10.038
Hunt GE, Malhi GS, Cleary M et al (2016a) Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990–2015: systematic review and meta-analysis. J Affect Disord 206:321–330
Hunt GE, Malhi GS, Cleary M et al (2016b) Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990–2015: systematic review and meta-analysis. J Affect Disord 206:331–349
Jarvis K, DelBello MP, Mills N et al (2008) Neuroanatomic comparison of bipolar adolescents with and without cannabis use disorders. J Child Adolesc Psychopharmacol 18:557–563. https://doi.org/10.1089/cap.2008.033
Jefsen OH, Speed MS, Speed D, Ostergaard SD (2020) Bipolar disorder and cannabis use: a bidirectional two-sample Mendelian randomization study. medRxiv 2020.06.11.20128470. https://doi.org/10.1101/2020.06.11.20128470
Johnson EC, Demontis D, Thorgeirsson TE et al (2020) A large-scale genome-wide association study meta-analysis of cannabis use disorder. The Lancet Psychiatry 7:1032–1045. https://doi.org/10.1016/S2215-0366(20)30339-4
Joormann J, Stanton CH (2016) Examining emotion regulation in depression: a review and future directions. Behav Res Ther 86:35–49. https://doi.org/10.1016/j.brat.2016.07.007
Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ (2009) Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: a randomized controlled trial of clinical efficacy. Addiction 104:378–388. https://doi.org/10.1111/j.1360-0443.2008.02444.x
Kendler KS, Gardner CO, Gatz M, Pedersen NL (2007) The sources of co-morbidity between major depression and generalized anxiety disorder in a Swedish national twin sample. Psychol Med 37:453–462. https://doi.org/10.1017/S0033291706009135
Kerridge BT, Pickering R, Chou P et al (2018) DSM-5 cannabis use disorder in the national epidemiologic survey on alcohol and related conditions-III: gender-specific profiles. Addict Behav 76:52–60. https://doi.org/10.1016/j.addbeh.2017.07.012
Kim SW, Dodd S, Berk L et al (2015) Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder. Psychiatry Investig 12:349–355. https://doi.org/10.4306/pi.2015.12.3.349
Kishi T, Yoshimura R, Fukuo Y et al (2013) The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder. Eur Arch Psychiatry Clin Neurosci 263:105–118. https://doi.org/10.1007/s00406-012-0337-4
Kober H, Devito EE, Deleone CM et al (2014) Cannabis abstinence during treatment and one-year follow-up: relationship to neural activity in men. Neuropsychopharmacology 39:2288–2298. https://doi.org/10.1038/npp.2014.82
Koob GF, Volkow ND (2010) Neurocircuitry of addiction. Neuropsychopharmacology 35:217–238
Kosiba JD, Maisto SA, Ditre JW (2019) Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis. Soc Sci Med 233:181–192. https://doi.org/10.1016/j.socscimed.2019.06.005
Kroon E, Kuhns L, Hoch E, Cousijn J (2020) Heavy cannabis use, dependence and the brain: a clinical perspective. Addiction 115:559–572. https://doi.org/10.1111/add.14776
Kroon E, Kuhns L, Cousijn J (2021) The short-term and long-term effects of cannabis on cognition: recent advances in the field. Curr Opin Psychol 38:49–55. https://doi.org/10.1016/j.copsyc.2020.07.005
Kvitland LR, Melle I, Aminoff SR et al (2015) Continued cannabis use at one year follow up is associated with elevated mood and lower global functioning in bipolar I disorder. BMC Psychiatry 15:1–7. https://doi.org/10.1186/s12888-015-0389-x
Kvitland LR, Ringen PA, Aminoff SR et al (2016) Duration of untreated illness in first-treatment bipolar I disorder in relation to clinical outcome and cannabis use. Psychiatry Res 246:762–768. https://doi.org/10.1016/j.psychres.2016.07.064
Lagerberg TV, Sundet K, Aminoff SR et al (2011) Excessive cannabis use is associated with earlier age at onset in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261:397–405. https://doi.org/10.1007/s00406-011-0188-4
Lagerberg TV, Kvitland LR, Aminoff SR et al (2014) Indications of a dose-response relationship between cannabis use and age at onset in bipolar disorder. Psychiatry Res 215:101–104. https://doi.org/10.1016/j.psychres.2013.10.029
Lagerberg TV, Icick R, Andreassen OA et al (2016) Cannabis use disorder is associated with greater illness severity in tobacco smoking patients with bipolar disorder. J Affect Disord 190:286–293. https://doi.org/10.1016/j.jad.2015.10.023
Lai HMX, Sitharthan T (2012) Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am J Drug Alcohol Abuse 38:567–574. https://doi.org/10.3109/00952990.2012.694523
Lai HMX, Cleary M, Sitharthan T, Hunt GE (2015) Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug Alcohol Depend 154:1–13
Lazareck S, Robinson JA, Crum RM, et al (2012) A longitudinal investigation of the role of self-medication in the development of comorbid mood and drug use disorders: findings from the national epidemiologic survey on alcohol and related conditions (NESARC). J Clin Psychiatry 73: https://doi.org/10.4088/JCP.11m07345
Leadbeater BJ, Ames ME, Linden-Carmichael AN (2019) Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults. Addiction 114:278–293. https://doi.org/10.1111/add.14459
Levin FR, Mariani J, Brooks DJ et al (2013) A randomized double-blind, placebo-controlled trial of venlafaxine-extended release for co-occurring cannabis dependence and depressive disorders. Addiction 108:1084–1094. https://doi.org/10.1111/add.12108
Lev-Ran S, Le Foll B, McKenzie K et al (2013) Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Res 209:459–465. https://doi.org/10.1016/j.psychres.2012.12.014
Lev-Ran S, Roerecke M, Le Foll B et al (2014) The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies. Psychol Med 44:797–810. https://doi.org/10.1017/S0033291713001438
Li X, Diviant JP, Stith SS et al (2020) The effectiveness of cannabis flower for immediate relief from symptoms of depression. Yale J Biol Med 93:251–264
Lichtenstein P, Yip BH, Björk C et al (2009) Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 373:234–239. https://doi.org/10.1016/S0140-6736(09)60072-6
Lowe DJE, Sasiadek JD, Coles AS, George TP (2019) Cannabis and mental illness: a review. Eur Arch Psychiatry Clin Neurosci 269:107–120. https://doi.org/10.1007/s00406-018-0970-7
Lucatch AM, Coles AS, Hill KP, George TP (2018) Cannabis and mood disorders. Curr Addict Reports 5:336–345. https://doi.org/10.1007/s40429-018-0214-y
Lucatch AM, Kloiber SM, Meyer JH et al (2020) Effects of extended cannabis abstinence in major depressive disorder. Can J Addict 11:33–41. https://doi.org/10.1097/cxa.0000000000000090
Lynskey MT, Glowinski AL, Todorov AA et al (2004) Major depressive disorder, suicidal ideation, and suicide attempt in twins discordant for cannabis dependence and early-onset cannabis use. Arch Gen Psychiatry. https://doi.org/10.1001/archpsyc.61.10.1026
Ma L, Hettema JM, Cousijn J et al (2020) Resting-state directional connectivity and anxiety and depression symptoms in adult cannabis users. Biol Psychiatry Cogn Neurosci Neuroimaging. https://doi.org/10.1016/j.bpsc.2020.09.015
Mackie K (2005) Distribution of cannabinoid receptors in the central and peripheral nervous system. In: Cannabinoids. Springer-Verlag, pp 299–325
Malhi GS, Byrow Y, Fritz K et al (2015) Mood disorders: neurocognitive models. Bipolar Disord 17:3–20. https://doi.org/10.1111/bdi.12353
Mammen G, Rueda S, Roerecke M, et al (2018) Association of cannabis with long-term clinical symptoms in anxiety and mood disorders: a systematic review of prospective studies. J Clin Psychiatry 79:0–0
Mars B, Heron J, Klonsky ED, et al (2019) Predictors of future suicide attempt among adolescents with suicidal thoughts or non-suicidal self-harm: a population-based birth cohort study. The Lancet Psychiatry. https://doi.org/10.1016/S2215-0366(19)30030-6
Martínez-Arán A, Vieta E, Reinares M et al (2004) Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 161:262–270. https://doi.org/10.1176/appi.ajp.161.2.262
Martz ME, Trucco EM, Cope LM et al (2016) Association of marijuana use with blunted nucleus accumbens response to reward anticipation. JAMA Psychiat 73:838–844. https://doi.org/10.1001/jamapsychiatry.2016.1161
Marwaha S, Winsper C, Bebbington P, Smith D (2018) Cannabis use and hypomania in young people: a prospective analysis. Schizophr Bull 44:1267–1274. https://doi.org/10.1093/schbul/sbx158
McElrath K, Taylor A, Tran KK (2016) Black–white disparities in criminal justice referrals to drug treatment: addressing treatment need or expanding the diagnostic net? Behav Sci 2016, Vol 6. Page 21(6):21. https://doi.org/10.3390/BS6040021
McGuffin P, Rijsdijk F, Andrew M et al (2003) The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60:497–502. https://doi.org/10.1001/ARCHPSYC.60.5.497
Mechoulam R, Parker LA (2013) The endocannabinoid system and the brain. Annu Rev Psychol 64:21–47
Mingtian Z, Shuqiao Y, Xiongzhao Z et al (2012) Elevated amygdala activity to negative faces in young adults with early onset major depressive disorder. Psychiatry Res - Neuroimaging 201:107–112. https://doi.org/10.1016/j.pscychresns.2011.06.003
Minocci D, Massei J, Martino A et al (2011) Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor. J Affect Disord 134:427–430. https://doi.org/10.1016/j.jad.2011.05.023
Miskowiak KW, Seeberg I, Kjaerstad HL et al (2019) Affective cognition in bipolar disorder: a systematic review by the ISBD targeting cognition task force. Bipolar Disord 21:686–719
Moitra E, Anderson BJ, Stein MD (2016) Reductions in cannabis use are associated with mood improvement in female emerging adults. Depress Anxiety 33:332–338. https://doi.org/10.1002/da.22460
Morgan CJA, Gardener C, Schafer G et al (2012) Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychol Med 42:391–400. https://doi.org/10.1017/S0033291711001322
Murphy FC, Rubinsztein JS, Michael A, et al (2001) Decision-making cognition in mania and depression. Psychol Med. https://doi.org/10.1017/S0033291701003804
Nesvåg R, Knudsen GP, Bakken IJ et al (2015) Substance use disorders in schizophrenia, bipolar disorder, and depressive illness: a registry-based study. Soc Psychiatry Psychiatr Epidemiol 50:1267–1276. https://doi.org/10.1007/s00127-015-1025-2
Nordström P, Åsberg M, Åberg-Wistedt A, Nordin C (1995) Attempted suicide predicts suicide risk in mood disorders. Acta Psychiatr Scand 92:345–350. https://doi.org/10.1111/j.1600-0447.1995.tb09595.x
Orri M, Séguin JR, Castellanos-Ryan N et al (2020) A genetically informed study on the association of cannabis, alcohol, and tobacco smoking with suicide attempt. Mol Psychiatry. https://doi.org/10.1038/s41380-020-0785-6
Østergaard MLD, Nordentoft M, Hjorthøj C (2017) Associations between substance use disorders and suicide or suicide attempts in people with mental illness: a Danish nation-wide, prospective, register-based study of patients diagnosed with schizophrenia, bipolar disorder, unipolar depression or personal. Addiction 112:1250–1259. https://doi.org/10.1111/add.13788
Pacek LR, Weinberger AH, Zhu J, Goodwin RD (2020) Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005–17: the role of differentially changing risk perceptions. Addiction 115:935–943. https://doi.org/10.1111/add.14883
Park SY, Holody KYLEJ (2018) Content, exposure, and effects of public discourses about marijuana: a systematic review. J Health Commun 23:1036–1043. https://doi.org/10.1080/10810730.2018.1541369
Pasman JA, Verweij KJH, Gerring Z et al (2018) GWAS of lifetime cannabis use reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Nat Neurosci. https://doi.org/10.1038/s41593-018-0206-1
Patten SB, Williams JVA, Lavorato DH et al (2015) Descriptive epidemiology of major depressive disorder in Canada in 2012. Can J Psychiatry 60:23–30. https://doi.org/10.1177/070674371506000106
Pedersen W (2008) Does cannabis use lead to depression and suicidal behaviours? A population-based longitudinal study. Acta Psychiatr Scand. https://doi.org/10.1111/j.1600-0447.2008.01259.x
Phan KL, Angstadt M, Golden J et al (2008) Cannabinoid modulation of amygdala reactivity to social signals of threat in humans. J Neurosci 28:2313–2319. https://doi.org/10.1523/JNEUROSCI.5603-07.2008
Pinto JV, Medeiros LS, Santana da Rosa G et al (2019) The prevalence and clinical correlates of cannabis use and cannabis use disorder among patients with bipolar disorder: a systematic review with meta-analysis and meta-regression. Neurosci Biobehav Rev 101:78–84. https://doi.org/10.1016/j.neubiorev.2019.04.004
Pizzagalli DA (2014) Depression, stress, and anhedonia: toward a synthesis and integrated model. Annu Rev Clin Psychol 10:393–423
Price C, Hemmingsson T, Lewis G et al (2009) Cannabis and suicide: longitudinal study. Br J Psychiatry 195:492–497. https://doi.org/10.1192/bjp.bp.109.065227
Radoman M, Hoeppner SS, Schuster RM et al (2019) Marijuana use and major depressive disorder are additively associated with reduced verbal learning and altered cortical thickness. Cogn Affect Behav Neurosci 19:1047–1058. https://doi.org/10.3758/s13415-019-00704-4
Rasic D, Weerasinghe S, Asbridge M, Langille DB (2013) Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend 129:49–53. https://doi.org/10.1016/j.drugalcdep.2012.09.009
Richter L, Pugh BS, Ball SA (2016) Assessing the risk of marijuana use disorder among adolescents and adults who use marijuana. 103109/0095299020161164711 43:247–260. https://doi.org/10.3109/00952990.2016.1164711
Ringen PA, Vaskinn A, Sundet K et al (2010) Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia. Psychol Med. https://doi.org/10.1017/S0033291709991620
Robinson LJ, Thompson JM, Gallagher P et al (2006) A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord 93:105–115. https://doi.org/10.1016/j.jad.2006.02.016
Roy MA, Neale MC, Pedersen NL et al (1995) A twin study of generalized anxiety disorder and major depression. Psychol Med 25:1037–1049. https://doi.org/10.1017/S0033291700037533
Rubino T, Vigano’ D, Realini N, et al (2008) Chronic Δ 9 -tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates. Neuropsychopharmacol 2008 3311 33:2760–2771. https://doi.org/10.1038/sj.npp.1301664
Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem Res. https://doi.org/10.1007/s11064-005-6978-1
Sagar KA, Dahlgren MK, Racine MT et al (2016) Joint effects: a pilot investigation of the impact of bipolar disorder and marijuana use on cognitive function and mood. PLoS ONE 11:e0157060. https://doi.org/10.1371/journal.pone.0157060
Schoeler T, Theobald D, Pingault J-B et al (2018) Developmental sensitivity to cannabis use patterns and risk for major depressive disorder in mid-life: findings from 40 years of follow-up. Psychol Med 48:2169–2176. https://doi.org/10.1017/S0033291717003658
Shbiro L, Hen-Shoval D, Hazut N et al (2019) Effects of cannabidiol in males and females in two different rat models of depression. Physiol Behav 201:59–63. https://doi.org/10.1016/J.PHYSBEH.2018.12.019
Shollenbarger S, Thomas AM, Wade NE et al (2019) Intrinsic frontolimbic connectivity and mood symptoms in young adult cannabis users. Front Public Heal 7:311. https://doi.org/10.3389/fpubh.2019.00311
Sideli L, Quigley H, La Cascia C, Murray RM (2020) Cannabis use and the risk for psychosis and affective disorders. J Dual Diagn 16:22–42. https://doi.org/10.1080/15504263.2019.1674991
Silote GP, Sartim A, Sales A et al (2019) Emerging evidence for the antidepressant effect of cannabidiol and the underlying molecular mechanisms. J Chem Neuroanat 98:104–116. https://doi.org/10.1016/j.jchemneu.2019.04.006
Smolkina M, Morley KI, Rijsdijk F et al (2017) Cannabis and depression: a twin model approach to co-morbidity. Behav Genet 47:394–404. https://doi.org/10.1007/s10519-017-9848-0
Solowij N, Broyd SJ, Beale C et al (2018) Therapeutic effects of prolonged cannabidiol treatment on psychological symptoms and cognitive function in regular cannabis users: a pragmatic open-label clinical trial. Cannabis Cannabinoid Res 3:21–34. https://doi.org/10.1089/can.2017.0043
Spechler PA, Orr CA, Chaarani B et al (2015) Cannabis use in early adolescence: evidence of amygdala hypersensitivity to signals of threat. Dev Cogn Neurosci 16:63–70. https://doi.org/10.1016/j.dcn.2015.08.007
Spechler PA, Stewart JL, Kuplicki R, et al (2020) Attenuated reward activations associated with cannabis use in anxious/depressed individuals. Transl Psychiatry 10: https://doi.org/10.1038/s41398-020-0807-9
Stiles BM, Fish AF, Vandermause R, Malik AM (2018) The compelling and persistent problem of bipolar disorder disguised as major depression disorder: an integrative review. J Am Psychiatr Nurses Assoc 24:415–425. https://doi.org/10.1177/1078390318784360
Strakowski SM, DelBello MP, Fleck DE et al (2007) Effects of co-occurring cannabis use disorders on the course of bipolar disorder after a first hospitalization for mania. Arch Gen Psychiatry 64:57–64. https://doi.org/10.1001/archpsyc.64.1.57
Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. 1157:1552–1562. https://doi.org/10.1176/APPI.AJP.157.10.1552
Sultan AA, Kennedy KG, Fiksenbaum L et al (2020) Neurostructural correlates of cannabis use in adolescent bipolar disorder. Int J Neuropsychopharmacol. https://doi.org/10.1093/ijnp/pyaa077
Teesson M, Slade T, Swift W et al (2012) Prevalence, correlates and comorbidity of DSM-IV cannabis use and cannabis use disorders in Australia. Aust N Z J Psychiatry 46:1182–1192. https://doi.org/10.1177/0004867412460591
Tijssen MJA, Van Os J, Wittchen HU et al (2010) Risk factors predicting onset and persistence of subthreshold expression of bipolar psychopathology among youth from the community. Acta Psychiatr Scand 122:255–266. https://doi.org/10.1111/j.1600-0447.2010.01539.x
Toftdahl NG, Nordentoft M, Hjorthøj C (2016) Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol 51:129–140. https://doi.org/10.1007/s00127-015-1104-4
Tyler E, Jones S, Black N et al (2015) The relationship between bipolar disorder and cannabis use in daily life: an experience sampling study. PLoS ONE 10:e0118916. https://doi.org/10.1371/journal.pone.0118916
UNODC (2020) World drug report. United Nations, New York, NY
Van der Pol P, Liebregts N, De Graaf R et al (2013) Mental health differences between frequent cannabis users with and without dependence and the general population. Addiction 108:1459–1469. https://doi.org/10.1111/add.12196
van Hell HH, Vink M, Ossewaarde L et al (2010) Chronic effects of cannabis use on the human reward system: an fMRI study. Eur Neuropsychopharmacol 20:153–163. https://doi.org/10.1016/J.EURONEURO.2009.11.010
Van Laar M, Van Dorsselaer S, Monshouwer K, De Graaf R (2007) Does cannabis use predict the first incidence of mood and anxiety disorders in the adult population? Addiction 102:1251–1260. https://doi.org/10.1111/j.1360-0443.2007.01875.x
Van Rossum I, Boomsma M, Tenback D et al (2009) Does cannabis use affect treatment outcome in bipolar disorder?: a longitudinal analysis. J Nerv Ment Dis 197:35–40. https://doi.org/10.1097/NMD.0b013e31819292a6
Walsh Z, Gonzalez R, Crosby K et al (2017) Medical cannabis and mental health: a guided systematic review. Clin Psychol Rev 51:15–29. https://doi.org/10.1016/j.cpr.2016.10.002
Walter T, Pocuca N, Young J, et al (2020) The relationship between cannabis use and cognition in people with bipolar disorder: a systematic scoping review. medRxiv 2020.04.24.20078535. https://doi.org/10.1101/2020.04.24.20078535
Wegbreit E, Cushman GK, Puzia ME et al (2014) Developmental meta-analyses of the functional neural correlates of bipolar disorder. JAMA Psychiat 71:926–935. https://doi.org/10.1001/jamapsychiatry.2014.660
Weinstock LM, Gaudiano BA, Wenze SJ et al (2016) Demographic and clinical characteristics associated with comorbid cannabis use disorders (CUDs) in hospitalized patients with bipolar i disorder. Compr Psychiatry 65:57–62. https://doi.org/10.1016/j.comppsych.2015.10.003
Weiss RD, Kolodziej M, Griffin ML et al (2004) Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. J Affect Disord 79:279–283. https://doi.org/10.1016/S0165-0327(02)00454-8
Wray NR, Gottesman II (2012) Using summary data from the Danish national registers to estimate heritabilities for schizophrenia, bipolar disorder, and major depressive disorder. Front Genet:118. https://doi.org/10.3389/FGENE.2012.00118
Wu LT, Zhu H, Mannelli P, Swartz MS (2017) Prevalence and correlates of treatment utilization among adults with cannabis use disorder in the United States. Drug Alcohol Depend 177:153–162. https://doi.org/10.1016/j.drugalcdep.2017.03.037
Zhang WN, Chang SH, Guo LY et al (2013) The neural correlates of reward-related processing in major depressive disorder: a meta-analysis of functional magnetic resonance imaging studies. J Affect Disord 151:531–539. https://doi.org/10.1016/j.jad.2013.06.039
Zorrilla I, Aguado J, Haro JM et al (2015) Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes? Acta Psychiatr Scand 131:100–110. https://doi.org/10.1111/acps.12366
Zuardi AW, Crippa JAS, Dursun SM et al (2010) Cannabidiol was ineffective for manic episode of bipolar affective disorder. J Psychopharmacol 24:135–137. https://doi.org/10.1177/0269881108096521
Funding
This research was supported by grant 1R01 DA042490-01A1 awarded to Janna Cousijn and Francesca Filbey from the National Institute on Drug Abuse/National Institutes of Health.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article belongs to a Special Issue on Cannabis and Cannabinoids
Rights and permissions
About this article
Cite this article
Kuhns, L., Kroon, E., Colyer-Patel, K. et al. Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence. Psychopharmacology 239, 1231–1249 (2022). https://doi.org/10.1007/s00213-021-06001-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00213-021-06001-8